Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10415 (
Bcl-2
)
33,771
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Adenovirus E1B 19 kDa protein protects against cell death induced by viral infection and certain external stimuli. The
Bcl-2
protein can functionally substitute for the E1B 19 kDa protein. To identify cellular targets for the 19 kDa protein, we used the two-hybrid screen in yeast. We have isolated cDNAs for three different proteins, designated Nip1, Nip2, and
Nip3
, that interact with the 19 kDa protein. Mutational analysis indicates that these proteins do not associate with 19 kDa mutants defective in suppression of cell death, suggesting a correlation between interaction of these proteins and suppression of cell death. These proteins also associate with discrete sequence motifs in the
Bcl-2
protein that are homologous to motifs of the 19 kDa protein. Our results suggest that two diverse proteins, the E1B 19 kDa and the
Bcl-2
proteins, promote cell survival through interaction with a common set of cellular proteins.
...
PMID:Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. 800 Nov 38
Nip3
(nineteen kD interacting protein-3) is an E1B 19K and
Bcl-2
binding protein of unknown function.
Nip3
is detected as both a 60- and 30-kD protein in vivo and in vitro and exhibits strong homologous interaction in a yeast two-hybrid system indicating that it can homodimerize.
Nip3
is expressed in mitochondria and a mutant (
Nip3
(163)) lacking the putative transmembrane domain and COOH terminus does not dimerize or localize to mitochondria. Transient transfection of epitope-tagged
Nip3
in Rat-1 fibroblasts and MCF-7 breast carcinoma induces apoptosis within 12 h while cells transfected with the
Nip3
(163) mutant have a normal phenotype, suggesting that mitochondrial localization is necessary for induction of cell death.
Nip3
overexpression increases the sensitivity to apoptosis induced by granzyme B and topoisomerase I and II inhibitors. After transfection, both
Nip3
and
Nip3
(163) protein levels decrease steadily over 48 h indicating that the protein is rapidly degraded and this occurs in the absence of cell death.
Bcl-2
overexpression initially delays the onset of apoptosis induced by
Nip3
but the resistance is completely overcome in longer periods of incubation.
Nip3
protein levels are much higher and persist longer in
Bcl-2
expressing cells. In conclusion,
Nip3
is an apoptosis-inducing dimeric mitochondrial protein that can overcome
Bcl-2
suppression.
...
PMID:The E1B 19K/Bcl-2-binding protein Nip3 is a dimeric mitochondrial protein that activates apoptosis. 939 66
We have identified Nix, a homolog of the E1B 19K/
Bcl-2
binding and pro-apoptotic protein
Nip3
. Human and murine Nix have a 56 and 53% amino acid identity to human and murine
Nip3
, respectively. The carboxyl terminus of Nix, including a transmembrane domain, is highly homologous to
Nip3
but it bears a longer and distinct asparagine/proline-rich N terminus. Human
Nip3
maps to chromosome 14q11.2-q12, whereas Nix/BNip3L was found on 8q21. Nix encodes a 23. 8-kDa protein but it is expressed as a 48-kDa protein, suggesting that it homodimerizes similarly to
Nip3
. Following transfection, Nix protein undergoes progressive proteolysis to an 11-kDa C-terminal fragment, which is blocked by the proteasome inhibitor lactacystin. Nix colocalizes with the mitochondrial matrix protein HSP60, and removal of the putative transmembrane domain (TM) results in general cytoplasmic and nuclear expression. When transiently expressed, Nix and
Nip3
but not TM deletion mutants rapidly activate apoptosis. Nix can overcome the suppressers
Bcl-2
and Bcl-XL, although high levels of Bcl-XL expression will inhibit apoptosis. We propose that Nix and
Nip3
form a new subfamily of pro-apoptotic mitochondrial proteins.
...
PMID:Nix and Nip3 form a subfamily of pro-apoptotic mitochondrial proteins. 986 3
The adenovirus E1B19K protein inhibits apoptosis induced by E1A and other divergent signals. The cellular proteins that interact with E1B19K have been analyzed by isolating cDNA clones by the yeast two hybrid system. One of these clones encodes B5 which consists of 219 amino acid residues and contains the putative BH3 and transmembrane regions. B5 binds strongly to
Nip3
and itself, weakly to E1B19K, but not to
Bcl-2
and localizes in nuclear envelope, endoplasmic reticulum and mitochondria. B5 has sequence homology with
Nip3
in the middle and C-terminal regions, but not in the N-terminal region. Unlike other E1B19K binding BH3 proteins so far characterized, B5 does not induce apoptosis, but inhibits apoptosis induced by
Nip3
. However the deletion mutant B5Delta1-31 lacking the N-terminus does induce apoptosis, although weaker than does
Nip3
, suggesting that the N-terminal region is masking the apoptosis-inducing capacity of B5.
...
PMID:A novel adenovirus E1B19K-binding protein B5 inhibits apoptosis induced by Nip3 by forming a heterodimer through the C-terminal hydrophobic region. 1038 23
BNIP3 (formerly
NIP3
) is a pro-apoptotic, mitochondrial protein classified in the
Bcl-2
family based on limited sequence homology to the
Bcl-2
homology 3 (BH3) domain and COOH-terminal transmembrane (TM) domain. BNIP3 expressed in yeast and mammalian cells interacts with survival promoting proteins
Bcl-2
, Bcl-X(L), and CED-9. Typically, the BH3 domain of pro-apoptotic
Bcl-2
homologues mediates
Bcl-2
/Bcl-X(L) heterodimerization and confers pro-apoptotic activity. Deletion mapping of BNIP3 excluded its BH3-like domain and identified the NH(2) terminus (residues 1-49) and TM domain as critical for
Bcl-2
heterodimerization, and either region was sufficient for Bcl-X(L) interaction. Additionally, the removal of the BH3-like domain in BNIP3 did not diminish its killing activity. The TM domain of BNIP3 is critical for homodimerization, pro-apoptotic function, and mitochondrial targeting. Several TM domain mutants were found to disrupt SDS-resistant BNIP3 homodimerization but did not interfere with its killing activity or mitochondrial localization. Substitution of the BNIP3 TM domain with that of cytochrome b(5) directed protein expression to nonmitochondrial sites and still promoted apoptosis and heterodimerization with
Bcl-2
and Bcl-X(L). We propose that BNIP3 represents a subfamily of
Bcl-2
-related proteins that functions without a typical BH3 domain to regulate apoptosis from both mitochondrial and nonmitochondrial sites by selective
Bcl-2
/Bcl-X(L) interactions.
...
PMID:BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. 1062 96
Many apoptotic signaling pathways are directed to mitochondria, where they initiate the release of apoptogenic proteins and open the proposed mitochondrial permeability transition (PT) pore that ultimately results in the activation of the caspase proteases responsible for cell disassembly. BNIP3 (formerly
NIP3
) is a member of the
Bcl-2
family that is expressed in mitochondria and induces apoptosis without a functional BH3 domain. We report that endogenous BNIP3 is loosely associated with mitochondrial membrane in normal tissue but fully integrates into the mitochondrial outer membrane with the N terminus in the cytoplasm and the C terminus in the membrane during induction of cell death. Surprisingly, BNIP3-mediated cell death is independent of Apaf-1, caspase activation, cytochrome c release, and nuclear translocation of apoptosis-inducing factor. However, cells transfected with BNIP3 exhibit early plasma membrane permeability, mitochondrial damage, extensive cytoplasmic vacuolation, and mitochondrial autophagy, yielding a morphotype that is typical of necrosis. These changes were accompanied by rapid and profound mitochondrial dysfunction characterized by opening of the mitochondrial PT pore, proton electrochemical gradient (Deltapsim) suppression, and increased reactive oxygen species production. The PT pore inhibitors cyclosporin A and bongkrekic acid blocked mitochondrial dysregulation and cell death. We propose that BNIP3 is a gene that mediates a necrosis-like cell death through PT pore opening and mitochondrial dysfunction.
...
PMID:BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. 1089 86
The ability to sense and respond to changes in oxygen availability is critical for many developmental, physiological, and pathological processes, including angiogenesis, control of blood pressure, and cerebral and myocardial ischemia. Hypoxia-inducible factor-1alpha (HIF-1alpha) is a basic-helix-loop-helix (bHLH)containing member of the PER-ARNT-SIM (PAS) family of transcription factors that plays a central role in the response to hypoxia. HIF-1alpha, and its relatives HIF-2alpha/endothelial PAS domain protein (EPAS) and HIF-3alpha, are induced in response to hypoxia and serve to coordinately activate the expression of target genes whose products facilitate cell survival under conditions of oxygen deprivation. When cells are exposed to chronic hypoxia, the protective response can fail, resulting in apoptosis. This study shows that transcription of the gene encoding
Nip3
, a proapoptotic member of the
Bcl-2
family of cell death factors, is strongly induced in response to hypoxia. The
Nip3
promoter contains a functional HIF-1-responsive element (HRE) and is potently activated by both hypoxia and forced expression of HIF-1alpha. Exposure of cultured cells to chronic hypoxia results in the accumulation of a protein recognized by antibodies raised against
Nip3
. This study demonstrates a direct link between HIF-1alpha and a proapoptotic member of the
Bcl-2
family and offers a reasonable physiological function for members of the
Bcl-2
subfamily, including
Nip3
and its close relative Nix. These observations indicate that
Nip3
may play a dedicated role in the pathological progression of hypoxia-mediated apoptosis, as observed after ischemic injury.
...
PMID:Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. 1092 63
Solid tumors contain regions of hypoxia, a physiological stress that can activate cell death pathways and, thus, result in the selection of cells resistant to death signals and anticancer therapy. Bcl2/adenovirus EIB 19kD-interacting protein 3 (BNIP3) is a cell death factor that is a member of the
Bcl-2
proapoptotic family recently shown to induce necrosis rather than apoptosis. Using cDNA arrays and serial analysis of gene expression, we found that hypoxia induces up-regulation of BNIP3 and its homologue,
Nip3
-like protein X. Analysis of human carcinoma cell lines showed that they are hypoxically regulated in many tumor types, as well as in endothelial cells and macrophages. Regulation was hypoxia inducible factor-1-dependent, and hypoxia inducible factor-1 expression was suppressed by von Hippel-Lindau protein in normoxic cells. Northern blotting and in situ hybridization analysis has revealed that these factors are highly expressed in human tumors compared with normal tissue and that BNIP3 is up-regulated in perinecrotic regions of the tumor. This study shows that genes regulating cell death can be hypoxically induced and are overexpressed in clinical tumors.
...
PMID:HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. 1155 32
Apoptosis is regulated by interaction of antiapoptotic
Bcl-2
family proteins with various proapoptotic proteins, several of which are also members of the
Bcl-2
family. BNIP3 (formerly
NIP3
) is a proapoptotic mitochondrial protein classified in the
Bcl-2
family based on limited sequence homology-3 (BH3) domain and COOH-terminal transmembrane domain. Sequence comparison of BNIP3 has indicated that there are several BNIP3 human homologs of this protein, like BNIP3L, Nix and BNIP3. We have cloned a new member of BNIP3 family from the cDNA library prepared from human dermal papilla cells and designated as BNIP3h. BNIP3h shows substantial homology with other BNIP3 family proteins. BNIP3h induced apoptosis from 24 hours after transfection in MCF7 cell lines and its apoptosis inducing activity is extended until 72 hours after transfection.
...
PMID:Cloning of BNIP3h, a member of proapoptotic BNIP3 family genes. 1164 54
The Kaposi's sarcoma-associated herpesvirus (KSHV) (or human herpesvirus 8) open reading frame (ORF) K15 encodes a putative integral transmembrane protein in the same genomic location as latent membrane protein 2A of Epstein-Barr virus. Ectopic expression of K15 in cell lines revealed the presence of several different forms ranging in size from full length, approximately 50 kDa, to 17 kDa. Of these different species the 35- and 23-kDa forms were predominant. Mutational analysis of the initiator AUG indicated that translation initiation from this first AUG is required for K15 expression. Computational analysis indicates that the different forms detected may arise due to proteolytic cleavage at internal signal peptide sites. We show that K15 is latently expressed in KSHV-positive primary effusion lymphoma cell lines and in multicentric Castleman's disease. Using a yeast two-hybrid screen we identified HAX-1 (HS1 associated protein X-1) as a binding partner to the C terminus of K15 and show that K15 interacts with cellular HAX-1 in vitro and in vivo. Furthermore, HAX-1 colocalizes with K15 in the endoplasmic reticulum and mitochondria. The function of HAX-1 is unknown, although the similarity of its sequence to those of
Nip3
and
Bcl-2
infers a role in the regulation of apoptosis. We show here that HAX-1 can form homodimers in vivo and is a potent inhibitor of apoptosis and therefore represents a new apoptosis regulatory protein. The putative functions of K15 with respect to its interaction with HAX-1 are discussed.
...
PMID:K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. 1175 70
1
2
Next >>